The latest closing stock price for Eliem Therapeutics as of September 18, 2024 is 7.98.
An investor who bought $1,000 worth of Eliem Therapeutics stock at the IPO in 2021 would have $-498 today, roughly 0 times their original investment - a -20.53% compound annual growth rate over 3 years.
The all-time high Eliem Therapeutics stock closing price was 28.61 on September 07, 2021.
The Eliem Therapeutics 52-week high stock price is 11.55, which is 44.7% above the current share price.
The Eliem Therapeutics 52-week low stock price is 2.35, which is 70.6% below the current share price.
The average Eliem Therapeutics stock price for the last 52 weeks is 4.69.
An investor who bought $1,000 worth of Eliem Therapeutics stock at the IPO in 2021 would have $-498 today, roughly 0 times their original investment - a -20.53% compound annual growth rate over 3 years.
The all-time high Eliem Therapeutics stock closing price was 28.61 on September 07, 2021.
The Eliem Therapeutics 52-week high stock price is 11.55, which is 44.7% above the current share price.
The Eliem Therapeutics 52-week low stock price is 2.35, which is 70.6% below the current share price.
The average Eliem Therapeutics stock price for the last 52 weeks is 4.69.